{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:48:52Z","timestamp":1792032532232,"version":"4.4.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Astrocytoma is a highly malignant tumor of the central nervous system with limited survival, despite standard multimodal therapies. While typically remains confined to the central nervous system, rare instances of extraneural and extracranial metastasis have been documented. The underlying pathophysiology remains poorly understood, with very few reported cases\u2014particularly in tumors harboring isocitrate dehydrogenase mutations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We describe the case of a 21-year-old female New Zealander of European descent with O<jats:sup>6<\/jats:sup>-methylguanine-DNA methyltransferase promoter-methylated, IDH1-R132H-mutant astrocytoma (World Health Organization 2021 central nervous system grade 4) containing a primitive neuroectodermal tumor-like component, which exhibited diffuse skeletal and leptomeningeal metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This case represents an unusual presentation of extraneural and extracranial metastatic spread in a young female New Zealander of European descent with an isocitrate dehydrogenase-mutant astrocytoma. Compared with recent literature, it is notable for early systemic dissemination and the coexistence of bone and leptomeningeal disease. A multidisciplinary discussion concluded that additional biopsy of metastatic sites was unwarranted owing to clear pathological correlation, clinical decline, and poor prognosis. Molecular characteristics such as cyclin-dependent kinase inhibitor 2A\/2B deletion may further refine classification. A review of current literature underscores the importance of the 2021 World Health Organization classification updates and highlights potential roles for epithelial\u2013mesenchymal transition and glymphatic dissemination in metastasis. Targeted therapies\u2014particularly isocitrate dehydrogenase inhibitors\u2014are under active investigation. This case reinforces the need for ongoing research into predictive biomarkers and individualized treatment strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13256-025-05474-x","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:42:43Z","timestamp":1759236163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Extraneural and extracranial metastatic astrocytoma with primitive neuroectodermal component: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8816-7061","authenticated-orcid":false,"given":"Frayne","family":"Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forough","family":"Foroughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Karanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"1","key":"5474_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cancers3010461","volume":"3","author":"P Beauchesne","year":"2011","unstructured":"Beauchesne P. Extra-neural metastases of malignant gliomas: myth or reality? Cancers. 2011;3(1):461\u201377.","journal-title":"Cancers"},{"issue":"5","key":"5474_CR2","first-page":"242","volume":"41","author":"C Schwartz","year":"2022","unstructured":"Schwartz C, Romagna A, Huemer F, Weiss L, Gatterbauer B, Woehrer A, et\u00a0al. Extensive leptomeningeal and systemic metastasis in glioblastoma: a clinicopathologic study. Clin Neuropathol. 2022;41(5):242\u20138.","journal-title":"Clin Neuropathol"},{"key":"5474_CR3","first-page":"23","volume":"174","author":"J Laurin","year":"2025","unstructured":"Laurin J, Barresi V, H\u00f6lsken A, Capper D, Reifenberger G. Genetic signatures associated with metastatic glioblastoma: a systematic review. World Neurosurg. 2025;174:23\u201331.","journal-title":"World Neurosurg"},{"issue":"4","key":"5474_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4103\/0028-3886.323892","volume":"69","author":"R Benson","year":"2021","unstructured":"Benson R, Mallick S, Purkait S, Haresh KP, Gupta S, Sharma MC, et\u00a0al. Glioblastoma with primitive neuroectodermal component treated with adjuvant radiotherapy and temozolomide: a pooled analysis of 23 patients. Neurol India. 2021;69(4):856\u201360.","journal-title":"Neurol India"},{"issue":"6","key":"5474_CR5","doi-asserted-by":"publisher","first-page":"300060520930459","DOI":"10.1177\/0300060520930459","volume":"48","author":"J Liu","year":"2020","unstructured":"Liu J, Shen L, Tang G, Tang S, Kuang W, Li H, et\u00a0al. Multiple extracranial metastases from glioblastoma multiforme: a case report and literature review. J Int Med Res. 2020;48(6):300060520930459.","journal-title":"J Int Med Res"},{"issue":"8","key":"5474_CR6","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et\u00a0al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"2","key":"5474_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-020-02250-7","volume":"141","author":"DE Reuss","year":"2021","unstructured":"Reuss DE, Kratz A, Sahm F, Capper D, Schrimpf D, Koelsche C, et\u00a0al. CDKN2A\/B deletion defines WHO grade 4 in IDH-mutant astrocytomas. Acta Neuropathol. 2021;141(2):291\u2013303.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"5474_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-022-04007-6","volume":"158","author":"MJ Strong","year":"2022","unstructured":"Strong MJ, Smith ER, Gill CM, D\u2019Amico RS, Cloney MB, Manley PE, et\u00a0al. Osseous metastasis in glioblastoma: a systematic review. J Neurooncol. 2022;158(1):41\u201352.","journal-title":"J Neurooncol"},{"key":"5474_CR9","first-page":"1198376","volume":"13","author":"YH Bae","year":"2024","unstructured":"Bae YH, Kim SM, Jeon HJ, Jung TY. Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration. Front Oncol. 2024;13:1198376.","journal-title":"Front Oncol"},{"issue":"3","key":"5474_CR10","first-page":"212","volume":"29","author":"N Majd","year":"2024","unstructured":"Majd N, Rivera-Zengotita M, Ahmed S, Elhammady M. Extraneural metastases of glioblastoma confirmed via next-generation sequencing. Oncologist. 2024;29(3):212\u20136.","journal-title":"Oncologist"},{"issue":"7","key":"5474_CR11","volume":"16","author":"NM Sudarsan","year":"2023","unstructured":"Sudarsan NM, Kumar MA, Lakshmi Narayanan V, Velayutham P, Manohar D, Sunder Singh JK. Skeletal metastases in an IDH1-mutant glioma: a rare presentation of WHO CNS grade 4 astrocytoma. BMJ Case Rep. 2023;16(7): e254267.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"5474_CR12","volume":"6","author":"MA Kurdi","year":"2023","unstructured":"Kurdi MA, Ghalib MH, Jamal S. Extracranial metastasis of glioblastoma outside CNS: pathogenesis revisited. Cancer Rep. 2023;6(1): e1714.","journal-title":"Cancer Rep"},{"issue":"23","key":"5474_CR13","first-page":"2216","volume":"388","author":"IK Mellinghoff","year":"2023","unstructured":"Mellinghoff IK, Ellingson BM, Touat M, Sadones J, van den Bent MJ, Penas-Prado M, et\u00a0al. Vorasidenib in IDH1- or IDH2-mutant low-grade glioma. N Engl J Med. 2023;388(23):2216\u201328.","journal-title":"N Engl J Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05474-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:42:54Z","timestamp":1759236174000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05474-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5474"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05474-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not required. Written informed consent was taken from the legal guardian prior to this submission and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors and I have no competing interests and no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}